Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-24-047644
Filing Date
2024-11-25
Accepted
2024-11-25 17:16:02
Documents
7

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 74717
2 formdefa14-a_001.jpg GRAPHIC 20767
3 formdefa14-a_002.jpg GRAPHIC 901931
4 formdefa14-a_003.jpg GRAPHIC 824737
5 formdefa14-a_004.jpg GRAPHIC 499190
6 formdefa14-a_005.jpg GRAPHIC 168564
7 formdefa14-a_006.jpg GRAPHIC 218086
  Complete submission text file 0001493152-24-047644.txt   3703343
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-27072 | Film No.: 241497083
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)